Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 17
Figure 5. North America Small Molecule API Market, 2017-2027, $ mn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of North America Small Molecule API Market 25
Figure 8. Primary Restraints and Impact Factors of North America Small Molecule API Market 28
Figure 9. Investment Opportunity Analysis 32
Figure 10. Porter’s Fiver Forces Analysis of North America Small Molecule API Market 35
Figure 11. Breakdown of North America Small Molecule API Market by Source, 2020-2027, % of Revenue 39
Figure 12. Contribution to North America 2021-2027 Cumulative Revenue by Source, Value ($ mn) and Share (%) 40
Figure 13. North America Small Molecule API Market: Synthetic API, 2017-2027, $ mn 41
Figure 14. North America Small Molecule API Market: Branded Synthetic API, 2017-2027, $ mn 42
Figure 15. North America Small Molecule API Market: Generic Synthetic API, 2017-2027, $ mn 43
Figure 16. North America Small Molecule API Market: Semi-synthetic API, 2017-2027, $ mn 44
Figure 17. North America Small Molecule API Market: Natural Origin, 2017-2027, $ mn 45
Figure 18. Breakdown of North America Small Molecule API Market by Type, 2020-2027, % of Revenue 46
Figure 19. Contribution to North America 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%) 47
Figure 20. North America Small Molecule API Market: Standard API, 2017-2027, $ mn 48
Figure 21. North America Small Molecule API Market: High Potency API (HPAPI), 2017-2027, $ mn 49
Figure 22. North America Small Molecule API Market: Branded HPAPI, 2017-2027, $ mn 50
Figure 23. North America Small Molecule API Market: Generic HPAPI, 2017-2027, $ mn 51
Figure 24. Breakdown of North America Small Molecule API Market by Therapeutic Area, 2020-2027, % of Revenue 53
Figure 25. Contribution to North America 2021-2027 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%) 53
Figure 26. North America Small Molecule API Market: Infectious Diseases, 2017-2027, $ mn 54
Figure 27. North America Small Molecule API Market: Oncology, 2017-2027, $ mn 55
Figure 28. North America Small Molecule API Market: Ophthalmology , 2017-2027, $ mn 56
Figure 29. North America Small Molecule API Market: Cardiovascular Disorders, 2017-2027, $ mn 57
Figure 30. North America Small Molecule API Market: Central Nervous System, 2017-2027, $ mn 58
Figure 31. North America Small Molecule API Market: Respiratory Disorders, 2017-2027, $ mn 59
Figure 32. North America Small Molecule API Market: Metabolic Diseases, 2017-2027, $ mn 60
Figure 33. North America Small Molecule API Market: Other Applications, 2017-2027, $ mn 61
Figure 34. Breakdown of North America Small Molecule API Market by Application, 2020-2027, % of Revenue 62
Figure 35. Contribution to North America 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 63
Figure 36. North America Small Molecule API Market: Clinical Use, 2017-2027, $ mn 64
Figure 37. North America Small Molecule API Market: Commercial Use, 2017-2027, $ mn 65
Figure 38. Breakdown of North America Small Molecule API Market by Manufacturer Type, 2020-2027, % of Revenue 66
Figure 39. Contribution to North America 2021-2027 Cumulative Revenue by Manufacturer Type, Value ($ mn) and Share (%) 67
Figure 40. North America Small Molecule API Market: Pharmaceutical Companies, 2017-2027, $ mn 68
Figure 41. Breakdown of North America Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue 69
Figure 42. North America Small Molecule API Market: CMOs, 2017-2027, $ mn 70
Figure 43. Breakdown of North America Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue 71
Figure 44. Breakdown of North America Small Molecule API Market by Country, 2020 and 2027, % of Revenue 73
Figure 45. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 74
Figure 46. U.S. Small Molecule API Market, 2017-2027, $ mn 76
Figure 47. Canada Small Molecule API Market, 2017-2027, $ mn 79
Figure 48. Small Molecule API Market in Mexico, 2017-2027, $ mn 81
Figure 49. Growth Stage of North America Small Molecule API Industry over the Forecast Period 83
Table 1. Snapshot of North America Small Molecule API Market in Balanced Perspective, 2020-2027 18
Table 2. Growth Rate of World GDP, 2020-2022 22
Table 3. Main Product Trends and Market Opportunities in North America Small Molecule API Market 31
Table 4. North America Small Molecule API Market by Source, 2017-2027, $ mn 39
Table 5. North America Small Molecule API Market: Synthetic API by Drug Type, 2017-2027, $ mn 41
Table 6. North America Small Molecule API Market by Type, 2017-2027, $ mn 46
Table 7. North America Small Molecule API Market: HPAPI by Drug Type, 2017-2027, $ mn 49
Table 8. North America Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 52
Table 9. North America Small Molecule API Market by Application, 2017-2027, $ mn 62
Table 10. North America Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 66
Table 11. North America Small Molecule API Market by Country, 2017-2027, $ mn 73
Table 12. U.S. Small Molecule API Market by Type, 2017-2027, $ mn 77
Table 13. U.S. Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 77
Table 14. U.S. Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 77
Table 15. Canada Small Molecule API Market by Type, 2017-2027, $ mn 80
Table 16. Canada Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 80
Table 17. Canada Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 80
Table 18. Mexico Small Molecule API Market by Type, 2017-2027, $ mn 82
Table 19. Mexico Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 82
Table 20. Mexico Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 82
Table 21. Aurobindo Pharma Ltd.: Company Snapshot 87
Table 22. Aurobindo Pharma Ltd.: Business Segmentation 87
Table 23. Aurobindo Pharma Ltd.: Product Portfolio 88
Table 24. Aurobindo Pharma Ltd.: Revenue, 2017-2019, $ mn 88
Table 25. Risk Evaluation for Investing in North America Market, 2020-2027 102
Table 26. Critical Success Factors and Key Takeaways 105
Safe and Secure SSl Encryption
Licensing options
3000
USD
You can select one of these options upon checking out
Allows one individual to access the purchased report
Allows up to five individuals to access the purchased report
Allows all employees of an organization to access the purchased report. Internal sharing only
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral
Use WELCOME to avail 10 % discount
North America: +1 201 793 8545 Europe: +44 20 8089 0049 Asia-Pacific: +91 7878231309
Email us on:- sales@bonafideresearch.com
Order Placed (27 September, 2023)
Notify To Team (27 September, 2023)
Report updation (28 September, 2023)
Report Quality Check (28 September, 2023)
Report Dispatch (29 September, 2023)
Hard Copy
Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer $1000 worth of FREE customization at the time of purchase
80% of the clinet request tailor made solution, how can we help you?
Avail customized purchase options to meet your exact research needs:
READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.
CEO
Vivek Arora
BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!
EXECUTIVE DIRECTOR
Rahul Roy
THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.
SALES DIRECTOR
Arjun Prasad
THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH
President
Manish Verma
Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
MARKETING DIRECTOR
Gautam Saxena
The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.
PRODUCT MANAGER
Tom Stone
I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.
Associate Director
Mark Wood
North America small molecule active pharmaceutical ingredient (API) market is expected to grow by 5.7% annually in the forecast period and reach $90.22 billion by 2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 26 tables and 49 figures, this 107-page report “North America Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America small molecule API market in every aspect of the classification from perspectives of Source, Type, Therapeutic Area, Application, Manufacturer Type, and Country. Based on Source, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Synthetic API o Branded Synthetic API o Generic Synthetic API • Semi-synthetic API • Natural Origin Based on Type, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Standard API • High Potency API (HPAPI) o Branded HPAPI o Generic HPAPI Based on Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Infectious Diseases • Oncology • Ophthalmology • Cardiovascular Disorders • Central Nervous System • Respiratory Disorders • Metabolic Diseases • Other Applications Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. o Clinical Use o Commercial Use Based on Manufacturer Type, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Pharmaceutical Companies • CMOs Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2017-2027. The breakdown of key national markets by Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Aurobindo Pharma Ltd. Cambrex Corporation Catalent, Inc. Dr. Reddy's Laboratories Ltd. GlaxoSmithKline plc Lonza Group Merck & Co., Inc. Mylan N.V. Novartis AG Pfizer Inc. Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Wuxi AppTec Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More